CLEBI vs SURGY Comparison
Price, market cap, valuation, profitability and leverage metrics of CLEBI and SURGY side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | CLEBI | SURGY | Sector median |
|---|---|---|---|
| Last price (TL) | 1,358.00 | 20.68 | 27.63 |
| Daily change | −3.00% | −5.05% | −6.41% |
| Market cap | TRY 33B | TRY 3.5B | TRY 7.9B |
| P/E | 9.91 | — | 11.16 |
| P/B | 4.85 | 0.34 | 1.28 |
| Dividend yield | 5.11% | — | 0.65% |
| Return on equity | 46.07% | −8.06% | 6.37% |
| Free float | 10.05% | 29.70% | 28.26% |
Popular Comparisons
Related Pages
About the CLEBI vs SURGY Comparison
Price, market cap, valuation multiples, profitability and leverage of CLEBI (Celebi) and SURGY (Sur Tatil Evleri GMYO) side by side as of Sep 28, 2026, 15:50. Of the 11 metrics compared, CLEBI leads in 6 and SURGY leads in 5.
Highlights: Daily change: CLEBI leads (−3.00% vs −5.05%). Market cap: CLEBI leads (TRY 33B vs TRY 3.5B). P/B: SURGY leads (0.34 vs 4.85). EV/Sales: CLEBI leads (3.88 vs 204.54). Gross margin: SURGY leads (47.03% vs 29.16%). EBITDA margin (annual): SURGY leads (2,129.73% vs 27.86%). Net margin (annual): CLEBI leads (16.41% vs −1,274.66%). Return on assets: CLEBI leads (14.01% vs −5.70%).
Frequently Asked Questions
Is CLEBI or SURGY cheaper?
By P/E, Tie is cheaper (9.91 vs —); by P/B, SURGY trades at the lower multiple (4.85 vs 0.34).
Which is more profitable, CLEBI or SURGY?
Annual net margin is 16.41% for CLEBI and −1,274.66% for SURGY; return on equity is 46.07% for CLEBI and −8.06% for SURGY.
Which is more leveraged, CLEBI or SURGY?
The leverage ratio is 65.70 for CLEBI and 30.27 for SURGY; net debt/EBITDA is 1.10 for CLEBI and — for SURGY. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.